Targeting novel signaling pathways for resistant acute myeloid leukemia

被引：58
|
作者：
Sakamoto, Kathleen M. [1 ]
Grant, Steven [2 ]
Saleiro, Diana [3 ,4 ]
Crispino, John D. [3 ,4 ]
Hijiya, Nobuko [6 ]
Giles, Francis [3 ,4 ]
Platanias, Leonidas [3 ,4 ,5 ]
Eklund, Elizabeth A. [3 ,4 ,5 ]
机构：
[1] Stanford Univ, Dept Pediat, Sch Med, Div Hematol Oncol, Stanford, CA 94305 USA
[2] Virginia Commonwealth Univ, Dept Med, Sch Med, Div Hematol Oncol & Palliat Care, Richmond, VA 23298 USA
[3] Northwestern Univ, Med Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA
[4] Northwestern Univ, Dept Med, Med Sch Med, Div Hematol Oncol, Chicago, IL 60611 USA
[5] Jesse Brown Vet Affairs Med Ctr, Dept Med, Div Hematol Oncol, Chicago, IL USA
[6] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Div Hematol Oncol, Chicago, IL 60611 USA
来源：
MOLECULAR GENETICS AND METABOLISM | 2015年 / 114卷 / 03期
关键词：
Acute myeloid leukemia; Signaling pathways; Novel therapies; Resistance; ELEMENT-BINDING-PROTEIN; UBIQUITIN LIGASE TRIAD1; GENE-EXPRESSION; TYROSINE-PHOSPHATASE; ENCODING GP91(PHOX); BCL-2; INHIBITION; CLONAL EVOLUTION; DUAL INHIBITION; JAK INHIBITORS; CREB;
D O I：
10.1016/j.ymgme.2014.11.017
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Acute myeloid leukemia (AML) is a hematologic malignancy that is the most common type of acute leukemia diagnosed in adults and the second most common type in children. The overall survival is poor and treatment is associated with significant complications and even death. In addition, a significant number of patients will not respond to therapy or relapse. In this review, several new signaling proteins aberrantly regulated in AML are described, including CREB, Triad1, Bcl-2 family members, Stat3, and mTOR/MEK. Identifying more effective and less toxic agents will provide novel approaches to treat AML. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码：397 / 402
页数：6
相关论文
共 50 条
  • [41] De Novo T-Cell Acute Lymphoblastic Leukemia Following Therapy for Acute Myeloid Leukemia is Sensitive to Agents Targeting Growth Factor Signaling and Apoptosis Pathways
    Finkbeiner, M.
    Meier-Stephenson, V.
    Narendran, A.
    Kolvear, F.
    Truong, T.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S115 - S116
  • [42] Serum-resistant CpG-STAT3 decoy for targeting survival and immune checkpoint signaling in acute myeloid leukemia
    Zhang, Qifang
    Hossain, Dewan Md Sakib
    Duttagupta, Priyanka
    Moreira, Dayson
    Zhao, Xingli
    Won, Haejung
    Buettner, Ralf
    Nechaev, Sergey
    Majka, Marcin
    Zhang, Bin
    Cai, Qi
    Swiderski, Piotr
    Kuo, Ya-Huei
    Forman, Stephen
    Marcucci, Guido
    Kortylewski, Marcin
    BLOOD, 2016, 127 (13) : 1687 - 1700
  • [43] Targeting Residual Chemotherapy-Resistant Acute Myeloid Leukemia Cells By a Novel Oxphos Inhibitor IACS010759
    Han, Lina
    Cavazos, Antonio
    Baran, Natalia
    Zhang, Qi
    Kuruvilla, Vinitha Mary
    Gay, Jason P.
    Feng, Ningping
    Battula, Venkata Lokesh
    Andreeff, Michael
    Kantarjian, Hagop M.
    Daver, Naval
    Marszalek, Joseph R.
    Konopleva, Marina
    BLOOD, 2017, 130
  • [44] Targeting Signaling Pathways in Chronic Lymphocytic Leukemia
    Muggen, Alice F.
    Singh, Simar P.
    Hendriks, Rudi W.
    Langerak, Anton W.
    CURRENT CANCER DRUG TARGETS, 2016, 16 (08) : 669 - 688
  • [45] Ponatinib regulates major signaling pathways in imatinib-resistant chronic myeloid leukemia cells
    Avci, C. Birav
    Kayabasi, C.
    Susluer, S. Yilmaz
    Balci, T.
    Saydam, G.
    Baran, Y.
    Gunduz, C.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S840 - S840
  • [46] The signaling pathways for compound DC072 induced apoptosis in acute myeloid leukemia
    Li, Kathy Keqin
    Chen, Limin
    Lu, Juyan
    Luo, Liufei
    Luo, Cheng
    FASEB JOURNAL, 2013, 27
  • [47] Targeting Apoptotic Pathways in Acute Myeloid Leukaemia
    Sillar, Jonathan R.
    Enjeti, Anoop K.
    CANCERS, 2019, 11 (11)
  • [48] Identification and targeting of novel CDK9 complexes in acute myeloid leukemia
    Beauchamp, Elspeth M.
    Abedin, Sameem M.
    Radecki, Sara G.
    Fischietti, Mariafausta
    Arslan, Ahmet Dirim
    Blyth, Gavin T.
    Yang, Angela
    Lantz, Connor
    Nelson, Alissa
    Goo, Young Ah
    Akpan, Imo
    Eklund, Elizabeth A.
    Frankfurt, Olga
    Fish, Eleanor N.
    Thomas, Paul M.
    Altman, Jessica K.
    Platanias, Leonidas C.
    BLOOD, 2019, 133 (11) : 1171 - 1185
  • [49] Targeting PRMT1 As a Novel Curative Therapy for Acute Myeloid Leukemia
    Su, Hairui
    Jin, Shuiling
    Shen, Yudao
    Kutny, Matthew A.
    Jin, Jian
    Luo, Minkui
    Zhao, Xinyang
    BLOOD, 2017, 130
  • [50] Genomics of Acute Myeloid Leukemia Diagnosis and Pathways
    Bullinger, Lars
    Doehner, Konstanze
    Doehner, Hartmut
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (09) : 934 - 946
12345